144 results on '"Liddell, Jeffrey R."'
Search Results
2. Microglial ferroptotic stress causes non-cell autonomous neuronal death
3. Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease
4. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice
5. Molecular mechanisms of cell death in neurological diseases
6. Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS.
7. A patient–derived blood–brain barrier model for screening copper bis(thiosemicarbazone) complexes as potential therapeutics in Alzheimer's disease
8. Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
9. Fundamental Neurochemistry Review: Copper availability as a potential therapeutic target in progressive supranuclear palsy: Insight from other neurodegenerative diseases.
10. Transdermal Application of Soluble CuII(atsm) Increases Brain and Spinal Cord Uptake Compared to Gavage with an Insoluble Suspension
11. Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex
12. Neuron-astrocyte transmitophagy is altered in Alzheimer's disease
13. Microglial ferroptotic stress causes non-cell autonomous neuronal death
14. Biometal Dyshomeostasis in Olfactory Mucosa of Alzheimer’s Disease Patients
15. Biometal Dyshomeostasis in Olfactory Mucosa of Alzheimer's Disease Patients
16. An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copper II
17. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates
18. Neuron-astrocyte transmitophagy is altered in Alzheimer's disease
19. Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer’s Disease
20. Alzheimer's disease alters astrocytic functions related to neuronal support and transcellular internalization of mitochondria
21. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43
22. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntingtonʼs disease affected brain
23. Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond
24. Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease
25. Disrupted copper availability in sporadic ALS: Implications for CuII(atsm) as a treatment option
26. CuII(atsm) significantly decreases microglial reactivity in patients with sporadic amyotrophic lateral sclerosis.
27. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress
28. Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson’s disease
29. CuII(atsm) Attenuates Neuroinflammation
30. Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
31. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway
32. Interplay between Nrf2 and NF-κB in Neuroinflammatory Diseases
33. Circumventing the Crabtree Effect: A method to induce lactate consumption and increase oxidative phosphorylation in cell culture
34. A versatile quantitative microdroplet elemental imaging method optimised for integration in biochemical workflows for low-volume samples.
35. Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
36. CuII(atsm) Attenuates Neuroinflammation.
37. ZnII(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism
38. Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration
39. Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43
40. Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?
41. Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder
42. Neuroprotective Copper Bis(thiosemicarbazonato) Complexes Promote Neurite Elongation
43. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis
44. Kinase Inhibitor Screening Identifies Cyclin-Dependent Kinases and Glycogen Synthase Kinase 3 as Potential Modulators of TDP-43 Cytosolic Accumulation during Cell Stress
45. Copper modulates the large dense core vesicle secretory pathway in PC12 cells
46. Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry
47. Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes
48. The challenges of using a copper fluorescent sensor (CS1) to track intracellular distributions of copper in neuronal and glial cells
49. An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copper II
50. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.